Acute Myeloid Leukemia
can be controlled and sometimes cured. Its prognosis depends on a variety of factors that is patient-specific.
AML can be kept in remission for a long period of time or even cured in some adults. Depending on certain factors such as, the characteristics of the leukemia cells. Some patients have a better prognosis in comparison to others.
Adults below 65 years 5-year survival rate - about 33%
Adults above 65 years - 4% only
Many people who live much longer than the average 5 years
The prognosis of a patient depends on the following factors:
Patientís age and race
- Younger patients and Caucasians have a good prognosis, while patients older than 60 years and patients of African- American descent have a poor prognosis Subtype of AML
- M3 has good prognosis while the M7 type has poor prognosis
Patientís response to therapy
AML that follows myelodysplastic syndrome
or myeloproliferative diseases has a poor prognosis
Elevated lactate dehydrogenase levels
has a poor prognosis Cytogenetics
plays an important role in predicting the progress of an AML patient as represented in the table below: